WEBINAR

Research in Motion with ioSkeletal Myocytes

Dr Will Bernard, Senior Scientist at bit.bio, and Dr Luke Flatt, Senior Scientist at Charles River discuss how bit.bio’s iPSC-derived ioSkeletal Myocytes can facilitate HTS workflows and accelerate research into muscle and metabolic disease.

Introducing human iPSC derived muscle cells for research and drug discovery

Introducing human iPSC-derived muscle cells for research and drug discovery.

 

This webinar showcases:

 

  • How highly-defined and characterised muscle cells can provide physiological relevance earlier in your research and drug development pipeline.
  • The potential of ioSkeletal Myocytes as a relevant translational model for research of muscle, neuromuscular and associated metabolic disorders.
  • How human induced skeletal myocytes have been generated by opti-ox™ cellular reprogramming to offer consistency at scale, easy culture and rapid maturity.

Watch the webinar

    Please complete the form below.








    Please confirm that we may add you to our mailing list, and send you our latest news and updates:
    Yes, please email me

    You can unsubscribe at any time by clicking the link in the footer of our emails. Privacy policy.

    This site is protected by reCAPTCHA and the Google Privacy Policy and Terms apply.

    Discover more resources

    webinars

    Webinars

    posters

    Posters

    publications

    Journals

    videos

    Videos